Updates

March 21, 2019March 21, 2019
With Improvements, ‘DriveSafe DriveAware’ Software Can Help Assess Huntington’s Patients’ Fitness to Drive, Study Shows

A software known as “DriveSafe DriveAware” can help evaluate if patients with Huntington’s disease still have the cognitive fitness needed to safely drive a ... Read more
March 21, 2019March 21, 2019
Embracing My CAG Score

Sometimes when you meet a person, there’s an immediate connection. Like kindred spirits, you become instant friends. When I attended my first Huntington Society ... Read more
March 19, 2019March 19, 2019
Biomarker Platform That May Track Huntington’s Decades Before Symptom Onset Receives FDA Letter of Support

The U.S. Food and Drug Administration (FDA) has issued a letter of support encouraging sRNAlytics to further develop its sRNA-FIND platform for discovering and monitoring ... Read more
March 14, 2019
Brexit Could Have Real Effects for UK Rare Disease Patients, Experts Warn

Madeline Collin, a 24-year-old activist with Gaucher disease, worries that patients like her will suffer deeply if Britain leaves the European Union (EU), as ... Read more
March 14, 2019March 13, 2019
Welcome to ‘Gene Positive’

When I was a child, my mother would tell me that if I didn’t eat my carrots, I would go blind. I do wear ... Read more

News

Mini Pig Model May Be Useful for Assessing Huntington’s Symptoms, Progression, Study Suggests
March 14, 2019March 14, 2019
Analysis of behavior patterns in genetically engineered mini pigs could be a valuable tool ...
News

MP101 Given FDA’s Orphan Drug Status for Potential to Treat Huntington’s Disease
March 12, 2019March 12, 2019
The U.S. Food and Drug Administration has granted orphan drug designation to MP101, an investigational mitochondrial-targeted ...
News

Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicist
March 12, 2019March 11, 2019
With each new advance in medicine comes ethical dilemmas, from fertility treatments and newborn ...
News

Gene Therapy Candidate AMT-130 Shows Promise in Preclinical Findings
March 7, 2019March 7, 2019
Encouraging new preclinical data on AMT-130, uniQure’s experimental gene therapy candidate for Huntington’s disease, ...
News

NIH Rare Disease Day Highlights Joint Networks Advancing Array of Research
March 5, 2019March 5, 2019
Rare diseases affect about 30 million Americans — roughly the same number as those ...
News

Tiny Chip Will Speed Up Genetic Diagnosis of Huntington’s Disease
February 28, 2019February 28, 2019
Researchers have developed a miniature device that can measure the length of disease-related DNA ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

WODC 2019 Organizers Expect 1,200 to Attend Rare Disease Conference in April
February 26, 2019February 25, 2019
The world’s biggest gathering of rare disease researchers, patient groups, pharmaceutical executives, and government ...
Cannabinoid-Based Treatment for Huntington’s Granted Orphan Drug Designation by FDA
February 21, 2019February 21, 2019
tMMJ-002, a cannabis investigational product for the treatment of Huntington’s disease, has been granted Orphan ...
Vienna to Host RARE2019 Meeting on Rare Diseases
February 21, 2019February 20, 2019
Emotional Recognition Defect Linked to Apathy in Huntington’s, Study Shows
February 19, 2019February 19, 2019
Researchers Get $6 Million to Continue Work on Huntington’s Stem Cell Therapy
February 14, 2019February 14, 2019
Fast Screening Strategy Identifies Potential New Inhibitors for Huntington’s Disease
February 12, 2019February 12, 2019

Patients, Family and Friends to Take Part in Variety of Rare Disease Day Events Worldwide
February 11, 2019
Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities ...
Impaired Glial Cell Development Contributes To Huntington’s, Mouse Study Suggests
February 7, 2019February 7, 2019
Phase 3 Trial of RG6042 Will Gauge Potential of Gene-silencing Approaches for Huntington’s, Other Diseases
February 5, 2019February 5, 2019
Huntington’s Patients in US and Canada Being Enrolled in Phase 3 Study of RG6042
January 31, 2019February 1, 2019

FDA Clears First Clinical Study of AMT-130 Gene Therapy in Huntington’s disease
January 29, 2019January 29, 2019
uniQure is launching a Phase 1/2 trial in the United States to evaluate the ...
Brain Neurons Disconnect from Each Other in Process Called Neuritosis, Mouse Study of Huntington’s Reveals
January 24, 2019January 24, 2019
Enrollment Completed for Phase 2 Trial Testing VX15/2503 in Early and Late Prodromal Huntington’s Patients
January 22, 2019January 22, 2019

News

Cerebellar Purkinje Cell Loss Linked to Huntington’s Motor Symptoms, Study Reports
January 17, 2019January 17, 2019
The loss of a type of nerve cell called a Purkinje cell in a ...
News

Asuragen Launches AmplideX as Faster Diagnostic Test for Huntington’s Disease
January 15, 2019January 15, 2019
Asuragen has launched a fast, easy-to-use and reliable diagnostic test, called AmplideX PCR/CE HTT Kit, ...
News

Machine Learning Applied to EEG Data May Serve as Huntington’s Biomarker, Study Suggests
January 10, 2019January 10, 2019
A method called quantitative electroencephalography (qEEG) enables the identification of Huntington’s gene carriers and ...
News

Most Transplanted Fetal Nerve Cells in Brain of Huntington’s Patients Do Not Thrive, Study Says
January 8, 2019January 8, 2019
While transplanted fetal nerve cells can survive long term in the brain of a ...
News

Huntexil Failed to Improve Motor Function of Huntington’s Patients in Phase 2 Trial
January 3, 2019January 3, 2019
Although well-tolerated, the investigational treatment Huntexil (pridopidine) failed to improve motor functions in a ...
News

Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish
December 21, 2018December 20, 2018
Cash-strapped governments across the 28-member European Union are struggling to control runaway healthcare expenditures ...
News

Gait, Balance Problems Can Help Diagnose Late-Onset Huntington’s, Study Finds
December 20, 2018December 20, 2018
Late-onset Huntington’s disease (emerging at age 59 or older), progresses similarly to common-onset Huntington’s except ...
News

European Huntington Association Promotes Awareness, Potential Gene Therapies
December 13, 2018December 13, 2018
There may be no cure yet for Huntington’s disease, but patients — and their ...
News

FDA Orphan Designation Moves Vybion’s Huntington’s Therapy Closer To Clinical Trial
December 6, 2018December 6, 2018
A therapy for Huntington’s disease called INT41 was granted orphan drug designation by the ...

May 23, 2016May 23, 2016

Blocking 2 Enzymes Seen to Reduce Nerve Cell Loss in Fruit Fly Model of Huntington’s

News

A collaboration between researchers at the University of Leicester, U.K., and the University of Maryland School of Medicine, Baltimore, may lead to a way of reversing some symptoms of neurogedenerative diseases, like Huntington’s, by blocking two specific enzymes of the kynurenine ... Read more

Subscribe to our mailing list

Pin It on Pinterest